Materias dentro de su búsqueda.
Mostrando 10,421 - 10,427 Resultados de 10,427 Para Buscar '"The Wake"', tiempo de consulta: 0.21s Limitar resultados
  1. 10421
    “…Individual morning self-management patterns over the study period were obtained by combining the times of waking, metformin ingestion, and glucose measurement. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Let Visuals Tell the Story: Medication Adherence in Patients with Type II Diabetes Captured by a Novel Ingestion Sensor Platform
  2. 10422
    “…Compared with the control group, trazodone significantly increased total sleep time (TST, min) (MD = 39.88, 95% CI 14.44–65.32, P = 0.002) and non-rapid eye movement stage 3 (N3, mixed min and %) (SMD = 1.61, 95% CI 0.69–2.53, P = 0.0006); trazodone significantly decreased latency to onset of persistent sleep (LPS, min) (MD = − 19.30, 95% CI − 37.28 to − 1.32, P = 0.04), non-rapid eye movement stage 1 (N1, mixed min and %) (SMD = − 0.62, 95% CI − 1.13 to − 0.12, P = 0.02), the number of awakenings (NAs, including both arousal times and arousal index) (SMD = − 0.67, 95% CI − 0.91 to − 0.42, P < 0.00001), and waking time after persistent sleep onset (WASO, mixed min and %) (SMD = − 0.42, 95% CI − 0.81, − 0.03, P = 0.04), with no obvious effect on non-rapid eye movement stage 2 (N2, mixed min and %) (SMD = − 0.15, 95% CI − 0.41 to 0.11, P = 0.25), rapid eye movement (REM, mixed min and %) (SMD = 0.22, 95% CI − 0.26 to 0.70, P = 0.37), rapid eye movement latency (REML, min) (MD = 2.33, 95% CI − 27.56 to 32.22, P = 0.88), or apnea–hypopnea index (AHI) (MD = − 4.21, 95% CI − 14.02 to 5.59, P = 0.40). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis
  3. 10423
    “…She then re-presented with a four-week history of fronto-temporal headache progressing to scalp tenderness and pain waking her from sleep. She denied visual symptoms or jaw claudication and there were no features of active lupus or RA. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    19. A case of giant cell arteritis (GCA) co-existent with systemic lupus erythematosus (SLE)/rheumatoid arthritis (RA) overlap syndrome
  4. 10424
    por Workman, R.L., V.D. Burkert, V. Crede, E. Klempt, U. Thoma, L. Tiator, K. Agashe, G. Aielli, B.C. Allanach, C. Amsler, M. Antonelli, E.C. Aschenauer, D.M. Asner, H. Baer, Sw. Banerjee, R.M. Barnett, L. Baudis, C.W. Bauer, J.J. Beatty, V.I. Belousov, J. Beringer, A. Bettini, O. Biebel, K.M. Black, E. Blucher, R. Bonventre, V.V. Bryzgalov, O. Buchmuller, M.A. Bychkov, R.N. Cahn, M. Carena, A. Ceccucci, A. Cerri, R. Sekhar Chivukula, G. Cowan, K. Cranmer, O. Cremonesi, G. D'Ambrosio, T. Damour, D. de Florian, A. de Gouvêa, T. DeGrand, P. de Jong, S. Demers, B.A. Dobrescu, M. D'Onofrio, M. Doser, H.K. Dreiner, P. Eerola, U. Egede, S. Eidelman, A.X. El-Khadra, J. Ellis, S.C. Eno, J. Erler, V.V. Ezhela, W. Fetscher, B.D. Fields, A. Freitas, H. Gallagher, Y. Gershtein, T. Gherghetta, M.C. Gonzalez-Garcia, M. Goodman, C. Grab, A.V. Gritsan, C. Grojean, D.E. Groom, M. Grünewald, A. Gurtu, T. Gutsche, H.E. Haber, Matthieu Hamel, C. Hanhart, S. Hashimoto, Y. Hayato, A. Hebecker, S. Heinemeyer, J.J. Hernández-Rey, K. Hikasa, J. Hisano, A. Höcker, J. Holder, L. Hsu, J. Huston, T. Hyodo, Al. Ianni, M. Kado, M. Karliner, U.F. Katz, M. Kenzie, V.A. Khoze, S.R. Klein, F. Krauss, M. Kreps, P. Križan, B. Krusche, Y. Kwon, O. Lahav, J. Laiho, L.P. Lellouch, J. Lesgourgues, A.R. Liddle, Z. Ligeti, C.-J. Lin, C. Lippmann, T.M. Liss, L. Littenberg, C. Lourenço, K.S. Lugovsky, S.B. Lugovsky, A. Lusiani, Y. Makida, F. Maltoni, T. Mannel, A.V. Manohar, W.J. Marciano, A. Masoni, J. Matthews, U.-G. Meißner, I.-A. Melzer-Pellmann, M. Mikhasenko, D.J. Miller, D. Milstead, R.E. Mitchell, K. Mönig, P. Molaro, F. Moortgat, M. Moskovic, K. Nakamura, M. Narain, P. Nason, S. Navas, A. Nelles, M. Neubert, P. Nevski, Y. Nir, K.A. Olive, C. Patrignani, J.A. Peacock, V.A. Petrov, E. Pianori, A. Pich, A. Piepke, F. Pietropaolo, A. Pomarol, S. Pordes, S. Profumo, A. Quadt, K. Rabbertz, J. Rademacker, G. Raffelt, M. Ramsey-Musolf, B.N. Ratcliff, P. Richardson, A. Ringwald, D.J. Robinson, S. Roesler, S. Rolli, A. Romaniouk, L.J. Rosenberg, J.L. Rosner, G. Rybka, M.G. Ryskin, R.A. Ryutin, Y. Sakai, S. Sarkar, F. Sauli, O. Schneider, S. Schönert, K. Scholberg, A.J. Schwartz, J. Schwiening, D. Scott, F. Sefkow, U. Seljak, V. Sharma, S.R. Sharpe, V. Shiltsev, G. Signorelli, M. Silari, F. Simon, T. Sjöstrand, P. Skands, T. Skwarnicki, G.F. Smoot, A. Soffer, M.S. Sozzi, S. Spanier, C. Spiering, A. Stahl, S.L. Stone, Y. Sumino, M.J. Syphers, F. Takahashi, M. Tanabashi, J. Tanaka, M. Taševský, K. Terao, K. Terashi, J. Terning, R.S. Thorne, M. Titov, N.P. Tkachenko, D.R. Tovey, K. Trabelsi, P. Urquijo, G. Valencia, R. Van de Water, N. Varelas, G. Venanzoni, L. Verde, I. Vivarelli, P. Vogel, W. Vogelsang, V. Vorobyev, S.P. Wakely, W. Walkowiak, C.W. Walter, D. Wands, D.H. Weinberg, E.J. Weinberg, N. Wermes, M. White, L.R. Wiencke, S. Willocq, C.G. Wohl, C.L. Woody, W.-M. Yao, M. Yokoyama, R. Yoshida, G. Zanderighi, G.P. Zeller, O.V. Zenin, R.-Y. Zhu, Shi-Lin Zhu, F. Zimmermann, P.A. Zyla, J. Anderson, T. Basaglia, P. Schaffner, W. Zheng
    Publicado 2022
    Enlace del recurso
    Enlace del recurso
    Review of Particle Physics: 2022
  5. 10425
    “…Youth spend most of their waking hours at school, and thus schools are important social environments for youth in recovery from substance use disorders. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review
  6. 10426
    “…Among current users of any tobacco product, 24.7% reported experiencing cravings to use tobacco products during the past 30 days and 13.7% reported wanting to use a tobacco product within 30 minutes of waking. Moreover, 57.8% of current tobacco product users reported they were seriously thinking about quitting the use of all tobacco products and 57.5% reported they had stopped using all tobacco products for ≥1 day because they were trying to quit. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tobacco Product Use and Associated Factors Among Middle and High School Students — 
United States, 2019
  7. 10427
    “…Among students who currently used any tobacco product, 27.2% had experienced cravings during the past 30 days; 19.5% reported wanting to use a tobacco product within 30 minutes of waking. Moreover, 65.3% of students who currently used tobacco products were seriously thinking about quitting the use of all products, and 60.2% had stopped using all products for ≥1 day because they were trying to quit during the past 12 months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Tobacco Product Use and Associated Factors Among Middle and High School Students — National Youth Tobacco Survey, United States, 2021
Herramientas de búsqueda: RSS